You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

5 July 2022

COVID-19 vaccines undergoing evaluation for provisional registration by the TGA

4 July 2022

COVID-19 vaccine batch release information is now available.

30 June 2022
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
27 June 2022
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
19 May 2022
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
2 May 2022

The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.

8 February 2022

Find information on complying with the rules around advertising and importing COVID-19 vaccines

20 December 2021
Frequently asked questions for new sponsors in relation to the supply of disinfectant products.
8 November 2021
Updated guidance clarifying the interaction between TGA and AHPRA advertising guidelines.
27 August 2021
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us